We are live on ! Find out more
BNTCW

Benitec Biopharma Limited
BNTCW

Delisted

BNTCW was delisted on the 14th of April, 2020.

Back to rankings

1 hedge funds and large institutions have $12K invested in Benitec Biopharma Limited in 2018 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

67% less funds holding

Funds holding: 3 → 1 (-2)

67% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 3

79% less capital invested

Capital invested by funds: $56K → $12K (-$44K)

Holders
1
Holders Change
-2
Holders Change %
-66.67%
% of All Funds
0.02%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
–
Closed
3
Calls
$21K
Puts
–
Net Calls
+$21K
Net Calls Change
+$21K

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
SM
Sabby Management
Florida
-$31.9K
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$20K
Name Holding Trade Value Shares
Change 		Change in
Stake
CH
1
CVI Holdings
Delaware
$12K +$17.7K +50,000 New
SM
2
Sabby Management
Florida
– -$31.9K -90,193 Closed
Susquehanna International Group
3
Susquehanna International Group
Pennsylvania
– -$20K -50,000 Closed

BNTCW Hedge Fund Activity: Q1 2018 in Review

1 of the 4,364 institutional investors tracked by Wall St. Rank reported a position in Benitec Biopharma Limited (BNTCW) for Q1 2018, worth a combined $12K — down 79% from $56K a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of BNTCW and 1 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Sabby Management, exiting entirely with an estimated $31.9K sold.

  • 1 institutional investor held Benitec Biopharma Limited (BNTCW) as of Q1 2018, down from 3 in Q4 2017.
  • Funds reported $12K of Benitec Biopharma Limited stock for Q1 2018, down 79% quarter-over-quarter.
  • 1 fund opened new Benitec Biopharma Limited positions in Q1 2018 and 3 closed out, a net change of -2 holders.
  • The largest Benitec Biopharma Limited seller in Q1 2018 was Sabby Management, an estimated $31.9K sold.

Based on aggregated 13F filings for Q1 2018.